Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 396

1.

Adipokines and insulin resistance.

Rabe K, Lehrke M, Parhofer KG, Broedl UC.

Mol Med. 2008 Nov-Dec;14(11-12):741-51. doi: 10.2119/2008-00058.Rabe. Epub 2008 Sep 17. Review.

2.

Adipokines: the missing link between insulin resistance and obesity.

Antuna-Puente B, Feve B, Fellahi S, Bastard JP.

Diabetes Metab. 2008 Feb;34(1):2-11. Review.

PMID:
18093861
3.

Adipokines in liver diseases.

Marra F, Bertolani C.

Hepatology. 2009 Sep;50(3):957-69. doi: 10.1002/hep.23046. Review.

PMID:
19585655
4.

Adipose tissue as an endocrine organ.

Galic S, Oakhill JS, Steinberg GR.

Mol Cell Endocrinol. 2010 Mar 25;316(2):129-39. doi: 10.1016/j.mce.2009.08.018. Epub 2009 Aug 31. Review.

PMID:
19723556
5.

Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases.

Tilg H, Moschen AR.

Clin Sci (Lond). 2008 Feb;114(4):275-88. doi: 10.1042/CS20070196. Review.

PMID:
18194136
6.

Markers of pro-inflammatory and pro-thrombotic state in the diagnosis of metabolic syndrome.

Odrowaz-Sypniewska G.

Adv Med Sci. 2007;52:246-50. Review.

PMID:
18217426
7.

Adipokines in obesity.

Ahima RS, Osei SY.

Front Horm Res. 2008;36:182-97. doi: 10.1159/0000115365. Review.

PMID:
18230903
8.

The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity.

Dyck DJ, Heigenhauser GJ, Bruce CR.

Acta Physiol (Oxf). 2006 Jan;186(1):5-16. Review.

PMID:
16497175
9.

Adipokines as emerging mediators of immune response and inflammation.

Lago F, Dieguez C, Gómez-Reino J, Gualillo O.

Nat Clin Pract Rheumatol. 2007 Dec;3(12):716-24. Review.

PMID:
18037931
10.

Adipose tissue and adipokines: for better or worse.

Guerre-Millo M.

Diabetes Metab. 2004 Feb;30(1):13-9. Review.

PMID:
15029093
11.

Insulin resistance in type 2 diabetes -- role of the adipokines.

Arner P.

Curr Mol Med. 2005 May;5(3):333-9. Review.

PMID:
15892652
12.

[Adipose tissue: a new endocrine organ].

Krysiak R, Okopień B, Herman ZS.

Przegl Lek. 2005;62(9):919-23. Review. Polish.

PMID:
16541730
13.

Adipokines as uremic toxins.

Teta D.

J Ren Nutr. 2012 Jan;22(1):81-5. doi: 10.1053/j.jrn.2011.10.029. Review.

PMID:
22200420
14.

Metabolic effects associated with adipose tissue distribution.

Zahorska-Markiewicz B.

Adv Med Sci. 2006;51:111-4. Review.

PMID:
17357288
15.

Role of adipokines in complications related to obesity: a review.

Gnacińska M, Małgorzewicz S, Stojek M, Łysiak-Szydłowska W, Sworczak K.

Adv Med Sci. 2009;54(2):150-7. doi: 10.2478/v10039-009-0035-2. Review.

PMID:
19875356
16.

[New approach in the interpretation of adipose tissue].

Antal M, Regöly-Mérei A.

Orv Hetil. 2010 Aug 1;151(31):1252-60. doi: 10.1556/OH.2010.28901. Review. Hungarian.

PMID:
20656662
17.

The new adipose tissue and adipocytokines.

Bulcão C, Ferreira SR, Giuffrida FM, Ribeiro-Filho FF.

Curr Diabetes Rev. 2006 Feb;2(1):19-28. Review.

PMID:
18220614
18.

Adipokines and etiopathology of metabolic disorders.

Al-Dokhi LM.

Saudi Med J. 2009 Sep;30(9):1123-32.

PMID:
19750255
19.

Adipokines: therapeutic targets for metabolic syndrome.

Kobayashi K.

Curr Drug Targets. 2005 Jun;6(4):525-9. Review.

PMID:
16026271
20.

Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis.

Spiroglou SG, Kostopoulos CG, Varakis JN, Papadaki HH.

J Atheroscler Thromb. 2010 Feb 26;17(2):115-30. Epub 2010 Feb 10.

Supplemental Content

Support Center